{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:48:54Z","timestamp":1789555734607,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,27]]},"DOI":"10.1097\/tp.0b013e3182a9274a","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T11:32:08Z","timestamp":1380799928000},"page":"1052-1058","source":"Crossref","is-referenced-by-count":21,"title":["Toxoplasma gondii Serostatus Is Not Associated With Impaired Long-Term Survival after Heart Transplantation"],"prefix":"10.1097","volume":"96","author":[{"given":"Jaap J.","family":"van Hellemond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"van Domburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozcan","family":"Birim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggie H.","family":"Balk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jacc.2007.07.068","article-title":"Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality.","volume":"50","author":"Arora","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1432-2277.2009.00993.x","article-title":"Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation.","volume":"23","author":"Doesch","year":"2010","journal-title":"Transpl Int"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","article-title":"Toxoplasma gondii: transmission, diagnosis and prevention.","volume":"8","author":"Hill","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/521246","article-title":"Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects.","volume":"45","author":"Demar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1469-0691.2008.02091.x","article-title":"Prevention of toxoplasmosis in transplant patients.","volume":"14","author":"Derouin","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1078\/0344-0338-00036","article-title":"Fulminant toxoplasmosis in a heart transplant recipient.","volume":"197","author":"Hermanns","year":"2001","journal-title":"Pathol Res Pract"},{"key":"R7-8-20210129","first-page":"838","article-title":"Effects of antibiotics on production of cytokines by human monocytes.","volume":"41","author":"Bailly","year":"1993","journal-title":"Pathol Biol (Paris)"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0735-1097(03)00645-4","article-title":"Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients.","volume":"42","author":"Hognestad","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation.","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00059-005-2685-6","article-title":"Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.","volume":"30","author":"Wenke","year":"2005","journal-title":"Herz"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/TP.0b013e318277e378","article-title":"Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.","volume":"95","author":"Guethoff","year":"2013","journal-title":"Transplantation"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"E798","DOI":"10.1016\/S0735-1097(13)60798-6","article-title":"Benefit of tracrolimusmycophenolate to reduce cardiac allograft vasculopathy after heart transplantation.","volume":"61","author":"Aaronson","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis.","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin Immunopathol"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pt.2011.08.001","article-title":"Toxoplasma gondii effectors are master regulators of the inflammatory response.","volume":"27","author":"Melo","year":"2011","journal-title":"Trends Parasitol"},{"key":"R16-8-20210129","first-page":"301","article-title":"Sequential OKT3 and cyclosporine after heart transplantation. A randomized study with single and cyclic OKT3.","volume":"5","author":"Balk","year":"1991","journal-title":"Clin Transplant"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1111\/tri.1992.5.s1.476","article-title":"Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study.","volume":"5","author":"Balk","year":"1992","journal-title":"Transpl Int"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007890-199607150-00011","article-title":"A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation.","volume":"62","author":"van Gelder","year":"1996","journal-title":"Transplantation"},{"key":"R19-8-20210129","first-page":"25","article-title":"Diagnosis of cardiac rejection by endomyocardial biopsy.","volume":"1","author":"Billingham","year":"1981","journal-title":"Heart transplant"},{"key":"R20-8-20210129","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/hrt.78.6.603","article-title":"Effect of adopting a new histological grading system of acute rejection after heart transplantation.","volume":"78","author":"Balk","year":"1997","journal-title":"Heart"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/JCM.27.3.529-535.1989","article-title":"Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients.","volume":"27","author":"Sluiters","year":"1989","journal-title":"J Clin Microbiol"},{"key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01728886","article-title":"Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.","volume":"21","author":"Balk","year":"1993","journal-title":"Infection"},{"key":"R25-8-20210129","first-page":"89","article-title":"Coronary artery disease after heart transplantation: timing of coronary arteriography.","volume":"12","author":"Balk","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1053-2498(00)00068-1","article-title":"Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis.","volume":"19","author":"Elhendy","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010.","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3182a9274a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:37:13Z","timestamp":1620977833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201312270-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3182a9274a","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,27]]}}}